pubmed-article:11530717 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:11530717 | lifeskim:mentions | umls-concept:C0521346 | lld:lifeskim |
pubmed-article:11530717 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:11530717 | lifeskim:mentions | umls-concept:C0030319 | lld:lifeskim |
pubmed-article:11530717 | pubmed:issue | 4 | lld:pubmed |
pubmed-article:11530717 | pubmed:dateCreated | 2001-9-3 | lld:pubmed |
pubmed-article:11530717 | pubmed:abstractText | The authors describe a new methodologically improved behavioral treatment for panic patients using respiratory biofeedback from a handheld capnometry device. The treatment rationale is based on the assumption that sustained hypocapnia resulting from hyperventilation is a key mechanism in the production and maintenance of panic. The brief 4-week biofeedback therapy is aimed at voluntarily increasing self-monitored end-tidal partial pressure of carbon dioxide (PCO2) and reducing respiratory rate and instability through breathing exercises in patients' environment. Preliminary results from 4 patients indicate that the therapy was successful in reducing panic symptoms and other psychological characteristics associated with panic disorder. Physiological data obtained from home training, 24-hour ambulatory monitoring pretherapy and posttherapy, and laboratory assessment at follow-up indicate that patients started out with low resting PCO2 levels, increased those levels during therapy, and maintained those levels at posttherapy and/or follow-up. Partial dissociation between PCO2 and respiratory rate questions whether respiratory rate should be the main focus of breathing training in panic disorder. | lld:pubmed |
pubmed-article:11530717 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11530717 | pubmed:language | eng | lld:pubmed |
pubmed-article:11530717 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11530717 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:11530717 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:11530717 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:11530717 | pubmed:month | Sep | lld:pubmed |
pubmed-article:11530717 | pubmed:issn | 0145-4455 | lld:pubmed |
pubmed-article:11530717 | pubmed:author | pubmed-author:RothW TWT | lld:pubmed |
pubmed-article:11530717 | pubmed:author | pubmed-author:WilhelmF HFH | lld:pubmed |
pubmed-article:11530717 | pubmed:author | pubmed-author:MeuretA EAE | lld:pubmed |
pubmed-article:11530717 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:11530717 | pubmed:volume | 25 | lld:pubmed |
pubmed-article:11530717 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:11530717 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:11530717 | pubmed:pagination | 584-605 | lld:pubmed |
pubmed-article:11530717 | pubmed:dateRevised | 2009-11-19 | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:meshHeading | pubmed-meshheading:11530717... | lld:pubmed |
pubmed-article:11530717 | pubmed:year | 2001 | lld:pubmed |
pubmed-article:11530717 | pubmed:articleTitle | Respiratory biofeedback-assisted therapy in panic disorder. | lld:pubmed |
pubmed-article:11530717 | pubmed:affiliation | Stanford University, Palo Alto, USA. alicia.meuret@stanford.edu | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Case Reports | lld:pubmed |
pubmed-article:11530717 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11530717 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11530717 | lld:pubmed |